Skip to content

Clinical trials

Phase 1 Retinal Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Phase: Phase 1 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20103
20141
20151
20183
20191
20212
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Adverum Biotechnologies, Inc.1
Axovia Therapeutics1
Cedars-Sinai Medical Center1
Gemini Therapeutics, Inc.1
Genzyme, a Sanofi Company1
Hadassah Medical Organization1
InnoVec Biotherapeutics Inc.1
Opthea Limited1
PYC Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration15
Eye Diseases7
Macular Degeneration7
Retinal Diseases6
Retinitis Pigmentosa4
Blindness1
Geographic Atrophy1
Glaucoma, Open-Angle1
Marijuana Abuse1
Neovascularization, Pathologic1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.